IQVIA Holdings

IQV · NYSE

$267.85+$1.97 (+0.74%)TodayMarket closed · Oct 20, 7:58 PM ET

Prev close $265.88

Latest news

Press releaseOct 15, 8:45 AM ETGlobe Newswire
The $1 Trillion AI Healthcare Revolution: A New Era of Medical Innovation Is Taking Shape
Press releaseOct 13, 7:03 AM ETBusiness Wire
IQVIA Selects Veeva Clinical Operations Applications
Press releaseOct 7, 4:15 PM ETBusiness Wire
IQVIA Launches IQVIA Life Science Models to Help Life Sciences Companies Predict Clinical Trial Outcomes
Press releaseOct 7, 4:15 PM ETBusiness Wire
IQVIA Launches IQVIA Explorer to Help Life Sciences Companies Make Better Commercial Decisions
Press releaseSep 29, 4:15 PM ETBusiness Wire
IQVIA to Announce Third-Quarter 2026 Results on October 27, 2026
Press releaseSep 9, 5:13 PM ETBusiness Wire
IQVIA Announces Pricing of Senior Notes
Press releaseSep 9, 8:15 AM ETBusiness Wire
IQVIA Announces Offering of Senior Notes
Press releaseSep 3, 4:15 PM ETBusiness Wire
IQVIA's Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster
Press releaseAug 27, 4:15 PM ETBusiness Wire
IQVIA Wins Multiple Industry Awards for AI and Technology Innovation Across Life Sciences and Healthcare
Press releaseAug 20, 4:15 PM ETBusiness Wire
IQVIA's AI-Enabled Clinical Decision Support Tool Wins 2026 AI Breakthrough Award for Predictive Modeling Solution of the Year
Press releaseAug 17, 4:15 PM ETBusiness Wire
IQVIA Ranked No. 1 Pharmaceutical Technology Provider by Everest Group
Press releaseAug 4, 4:15 PM ETBusiness Wire
IQVIA and Medera to Advance Cardiac Gene Therapy and Human-Based Drug Discovery
NewsJul 28, 1:21 PM ETPiero Cingari
Nasdaq 100 Enters Correction, SanDisk Sinks Over 50% From Peak: Stock Market Today
NewsJul 28, 8:05 AM ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
NewsJul 28, 7:01 AM ET
IQVIA Hldgs Q2 Adj. EPS $3.15 Beats $3.03 Estimate, Sales $4.368B Beat $4.301B Estimate
Press releaseJul 28, 7:00 AM ETBusiness Wire
IQVIA Reports Second-Quarter 2026 Results
Press releaseJul 16, 1:39 PM ETBusiness Wire
IQVIA's Dr. Cynthia Verst Testifies Before Congressional Subcommittee on More Efficient Path to Early Clinical Development in the United States
Press releaseJul 8, 4:15 PM ETBusiness Wire
IQVIA to Announce Second-Quarter 2026 Results on July 28, 2026
Press releaseJun 15, 9:00 AM ETBusiness Wire
Wiley and IQVIA Release Cross-Sector Report on AI's Promise and Pressure Points Across Healthcare Value Chain
Press releaseJun 4, 10:51 AM ETBusiness Wire
IQVIA Announces Pricing of Senior Notes
Press releaseJun 3, 2:53 AM ETBusiness Wire
IQVIA Announces Offering of Senior Notes
Press releaseMay 26, 4:15 PM ETBusiness Wire
IQVIA CEO to Speak at Jefferies Global Healthcare Conference
Press releaseMay 13, 4:30 PM ETBusiness Wire
IQVIA and Kexing Biopharm Expand Strategic Collaboration to Accelerate Global Biosimilar Development using AI-Enabled Capabilities
Press releaseMay 7, 5:15 PM ETBusiness Wire
IQVIA Board of Directors Approves $2 Billion Increase in Share Repurchase Authorization
Press releaseMay 6, 4:15 PM ETBusiness Wire
IQVIA CFO to Speak at Bank of America Health Care Conference 2026
NewsMay 5, 7:12 AM ET
Earnings Scheduled For May 5, 2026
NewsMay 5, 7:01 AM ET
IQVIA Hldgs Q1 Adj. EPS $2.90 Beats $2.82 Estimate, Sales $4.151B Beat $4.100B Estimate.
Press releaseMay 5, 7:00 AM ETBusiness Wire
IQVIA Reports First-Quarter 2026 Results
Press releaseApr 15, 4:15 PM ETBusiness Wire
IQVIA to Announce First-Quarter 2026 Results on May 5, 2026
Press releaseMar 16, 4:30 PM ETBusiness Wire
IQVIA Unveils IQVIA.ai, a Unified Agentic AI Platform Powered by NVIDIA to Improve Efficiency and Decision Making Across Life Sciences
NewsFeb 5, 6:11 AM ET
Earnings Scheduled For February 5, 2026
NewsFeb 4, 12:05 PM ET
Earnings Outlook For IQVIA Hldgs
NewsOct 28, 1:23 PM ETPiero Cingari
Nasdaq 100 Hits 26,000, Gold Falls Below $4,000: What's Moving Markets Tuesday?
NewsOct 1, 4:22 PM ETPiero Cingari
Trump-Pfizer Deal Pushes Health Care Stocks To Best Rally In 5 Years

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

The $1 Trillion AI Healthcare Revolution: A New Era of Medical Innovation Is Taking Shape

IQVIA Selects Veeva Clinical Operations Applications

IQVIA Launches IQVIA Life Science Models to Help Life Sciences Companies Predict Clinical Trial Outcomes

IQVIA Launches IQVIA Explorer to Help Life Sciences Companies Make Better Commercial Decisions

IQVIA to Announce Third-Quarter 2026 Results on October 27, 2026

IQVIA Announces Pricing of Senior Notes

IQVIA Announces Offering of Senior Notes

IQVIA's Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster

IQVIA Wins Multiple Industry Awards for AI and Technology Innovation Across Life Sciences and Healthcare

IQVIA's AI-Enabled Clinical Decision Support Tool Wins 2026 AI Breakthrough Award for Predictive Modeling Solution of the Year

IQVIA Ranked No. 1 Pharmaceutical Technology Provider by Everest Group

IQVIA and Medera to Advance Cardiac Gene Therapy and Human-Based Drug Discovery

Nasdaq 100 Enters Correction, SanDisk Sinks Over 50% From Peak: Stock Market Today

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

IQVIA Hldgs Q2 Adj. EPS $3.15 Beats $3.03 Estimate, Sales $4.368B Beat $4.301B Estimate

IQVIA Reports Second-Quarter 2026 Results

IQVIA's Dr. Cynthia Verst Testifies Before Congressional Subcommittee on More Efficient Path to Early Clinical Development in the United States

IQVIA to Announce Second-Quarter 2026 Results on July 28, 2026

Wiley and IQVIA Release Cross-Sector Report on AI's Promise and Pressure Points Across Healthcare Value Chain

IQVIA Announces Pricing of Senior Notes

IQVIA Announces Offering of Senior Notes

IQVIA CEO to Speak at Jefferies Global Healthcare Conference

IQVIA and Kexing Biopharm Expand Strategic Collaboration to Accelerate Global Biosimilar Development using AI-Enabled Capabilities

IQVIA Board of Directors Approves $2 Billion Increase in Share Repurchase Authorization

IQVIA CFO to Speak at Bank of America Health Care Conference 2026

Earnings Scheduled For May 5, 2026

IQVIA Hldgs Q1 Adj. EPS $2.90 Beats $2.82 Estimate, Sales $4.151B Beat $4.100B Estimate.

IQVIA Reports First-Quarter 2026 Results

IQVIA to Announce First-Quarter 2026 Results on May 5, 2026

IQVIA Unveils IQVIA.ai, a Unified Agentic AI Platform Powered by NVIDIA to Improve Efficiency and Decision Making Across Life Sciences

Earnings Scheduled For February 5, 2026

Earnings Outlook For IQVIA Hldgs

Nasdaq 100 Hits 26,000, Gold Falls Below $4,000: What's Moving Markets Tuesday?

Trump-Pfizer Deal Pushes Health Care Stocks To Best Rally In 5 Years